Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.
about
Progress in treatment of ANCA-associated vasculitisSilica exposure and systemic vasculitisThe Prevalence and Management of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in ChinaAnimal models of anti-neutrophil cytoplasmic antibody-associated vasculitisCurrent and future prospects in the management of granulomatosis with polyangiitis (Wegener's granulomatosis)Experimentally-induced anti-myeloperoxidase vasculitis does not require properdin, MASP-2 or bone marrow-derived C5Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosisThe immunopathology of ANCA-associated vasculitisSurvival of patients with ANCA-associated vasculitis on chronic dialysis: data from the French REIN registry from 2002 to 2011.Pauci-immune crescentic glomerulonephritis superimposed on diabetic glomerulosclerosisClinical Predictors of Outcome in Patients with Anti-neutrophil Cytoplasmic Autoantibody-related Renal Vasculitis: Experiences from a Single-center.Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement--a prospective, open-label pilot trial.Prediction of ESRD in pauci-immune necrotizing glomerulonephritis: quantitative histomorphometric assessment and serum creatinineNegative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse.Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans.Management of ANCA-associated vasculitis: Current trends and future prospectsEfficacy of remission-induction regimens for ANCA-associated vasculitis.High-mobility group box-1 protein (HMGB1) is increased in antineutrophilic cytoplasmatic antibody (ANCA)-associated vasculitis with renal manifestationsPlasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysisFatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitisValidation of the new classification of pauci-immune glomerulonephritis in a United States cohort and its correlation with renal outcomeImmunotherapy for autoimmune and inflammatory renal diseases.Improved prognosis in Norwegian patients with glomerulonephritis associated with anti-neutrophil cytoplasmic antibodies.Clinical [corrected] and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre.Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective study.ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.Urinary FSP1 is a biomarker of crescentic GNDevelopment of comprehensive disease assessment in systemic vasculitis.Necrotizing and crescentic glomerulonephritis presenting with preserved renal function in patients with underlying multisystem autoimmune disease: a retrospective case series.Pro: Should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab?Immunization in Patients with Rheumatic Diseases: A Practical Guide for General Practitioners.Outcome and treatment of elderly patients with ANCA-associated vasculitis.urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitisProteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse.A CD8+ T cell transcription signature predicts prognosis in autoimmune disease.B Cells, Antibodies, and More.Intravenous cyclophosphamide and plasmapheresis in dialysis-dependent ANCA-associated vasculitisLymphopenia and treatment-related infectious complications in ANCA-associated vasculitis.EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
P2860
Q21195258-A970C337-D8B9-485F-B087-AD12781CF362Q24817062-72938C23-6961-4EA6-BC06-33078C4D5683Q26740453-6E9A21AD-F69D-427E-8152-CDFE3175BF04Q26864089-C1477A6E-8A5F-4D72-86A8-DBCA9B7E3451Q27025692-CD8A2B30-23F4-40BC-AC1E-64BA07DBB357Q27468849-0C3BA42A-2680-4C2C-80FA-3BFCA60E4EC8Q28389271-29C54CA2-8019-45BD-BF6C-D9919CB0571BQ28391531-6DAE3D5F-1208-4987-814F-965C9AD85B99Q30764638-9636C273-7D7E-41DF-8FF7-5D81951D4F1FQ33338386-C36FE823-F541-4E9A-AFA6-4A401FFA13D7Q33608983-6F223220-2E01-4DE2-9570-1025A5350B64Q33684065-CA0C833A-32FF-4E18-BB5A-B5A757EB0DB8Q33697927-2BEE0B99-ECDB-466E-BEBD-61D6E8ADF3FDQ33771970-98F0D433-32E0-47F7-8BA6-8D57920B02D3Q33862188-74D9E3F8-9F89-4F57-AE71-B377F7779674Q33947599-65645685-2F80-467A-96A1-658A19310D66Q34037683-F87D1D1C-F14C-491D-8159-E8A5B7BD48B9Q34500661-87D4E071-6EC6-4440-8896-B4845754E851Q34708735-C546E4C4-2CE2-42D3-B487-AD624DF7FD41Q34965751-70140627-9C6C-4D62-98E6-BE6640DFB831Q35007874-24EF380F-B04B-4701-9041-4C8AD85CDA1DQ35144046-A4F0F21F-21AE-4C3B-8768-FB6A032629AFQ35212086-2C811EF1-4F38-4107-966B-3411B5734E50Q35523066-9D705101-FFF4-4DFD-8D55-B9FB9E7CD7FFQ35673484-7C48778F-9088-4045-A741-C0C19ECEBF08Q35678050-828C1A6F-463D-4773-832D-338C3DEAB11CQ35715722-5022C67D-3643-4B64-BDAA-54F8C570061FQ35759939-84DECFAE-8ACB-4A3E-A6F8-A527DDC08EC7Q35767701-80CAB968-7BEA-45AC-894D-4CDBBE7111E1Q35777619-A1D50C8F-38B6-40F8-BBD5-05EF4327039FQ35792458-CE56838D-A653-4384-BAE7-10CC9C275A8DQ35816989-782DAFE4-EB37-458D-8D0F-619C36D91980Q35861689-FC94556B-AB5E-43A2-BE3F-08A3EFA86407Q36104863-6D89721B-EBA3-4CC1-B90F-8A9B4826DDADQ36223713-58287BAD-CD95-40CF-A261-DE7A28198D0DQ36417832-5FCC5EA7-406E-4344-948A-E3754493DA23Q36432935-B6F5296D-059E-4BE5-AA83-2952428472C6Q36583330-61EF4FA3-7D44-441E-8DCF-F8FE9426E556Q36652819-31D1EBDF-C11F-45AF-8D03-4A64865EDAF8Q36684589-779B51AB-A2A6-4DA7-B687-AEB709F69727
P2860
Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.
@ast
Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.
@en
type
label
Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.
@ast
Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.
@en
prefLabel
Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.
@ast
Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.
@en
P2093
P1476
Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.
@en
P2093
Aine Burns
Anthony D Booth
Charles D Pusey
David R W Jayne
Gill Gaskin
Guy H Neild
Martin Plaisance
Mike K Almond
Pan-Thames Renal Research Group
Peter Ellis
P304
P356
10.1016/S0272-6386(03)00025-8
P577
2003-04-01T00:00:00Z